MDMA Member-Only Webinar: Program to Accelerate Regulatory & Reimbursement Decisions
Tell a Friend About This EventTell a Friend
 

6/21/2017
When: June 21, 2017
1pm - 3pm ET
Where: United States
Presenter: EXCITE International
Contact: Sheri DeVinney
202-354-7171


Online registration is closed.
« Go to Upcoming Event List  

 

On Wednesday, June 21, 2017, MDMA will present a Member-only (no cost) webinar, "Program to Accelerate Regulatory & Reimbursement Decisions", hosted by EXCITE International.

Learn more about how EXCITE International, a not-for-profit organization, can help your medical technology company navigate the notoriously complex pathway from innovation to adoption through a single streamlined EXCITE pathway to global adoption through its collaboration involving key payers, health systems/ organizations, international clinical trials scientists, patients and international expert end-users of your technology. The EXCITE approach offers a lower risk, cost effective large-scale alternative to the existing post-market health technology assessment which currently leads to high rejection rates of 50-95% for regulatory-approved technologies.

EXCITE International has assembled one of the largest infrastructures across the U.S. and Canada and working to consolidate its positioning with the Netherlands and Norway as the bridge-head into Europe. This global approach follows a successful proof of concept pilot undertaken in Ontario, Canada, since 2012 of 11 medical technologies through the MaRS EXCITE program.

If selected by EXCITE International (EI), based on the potential for your technology to add to and enhance existing treatments, the large infrastructure and alliances EXCITE International has assembled will work with your company to help pull your technology into key global markets. While EI cannot guarantee final adoption by health systems, by working closely with them, the process will reduce the risk of downstream rejection of regulatory approved technologies.

Presenters will include Mark Leahey, CEO, MDMA; Dr. Les Levin, Chief Executive and Scientific Officer, EI; Naomi Aronson, Phd, Chair of the EI Payers' Advisory Committee (PAC) and Executive Director Clinical Evaluation, Innovation and Policy Office of Clinical Affairs, Blue Cross Blue Shield Association, U.S.; Dr. Jo Carol Hiatt, PAC, member and Chair, National Product Council, Kaiser Permanente; and Bryan Luce, PhD, Chair of the EI Scientific Collaboration.

Members can view an archived audio recording of this webinar by CLICKING HERE.